Two AI-based science assistants succeed with drug-retargeting tasks

Nature highlighted two AI science assistants, Google’s Co-Scientist and FutureHouse’s Robin, that scan biomedical literature and generate testable hypotheses.

The systems can suggest existing drugs for repurposing, pointing researchers toward candidate treatments for diseases such as acute myeloid leukemia and macular degeneration.

By sifting through overwhelming biology research, these tools may surface overlooked links across fields and speed up scientific discovery.